BioSpace News Archive

Biotech Bay

NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy

Makes board and executive changes and reduces U.S. sales organization to focus only on high-performing, high potential sales territories and specialty pharmacy channel expansion

March 12, 2019
·
6 min read
Biotech Beach

International Glaucoma Study Confirms Long-term Efficacy and Safety Profile of Glaukos iStent® Implantation in Combination with Cataract Surgery

At 5 Years Postoperative, Mean IOP Decreased 38% to 14.7 mmHg and Topical Ocular Hypotensive Medication Use Declined 75% while Safety Profile Remained Favorable

March 12, 2019
·
10 min read
Business

Statement from the Chief Public Health Officer of Canada, Dr. Theresa Tam, on the current measles outbreak and vaccine hesitancy

As Canada’s Chief Public Health Officer, I am very concerned to see vaccine-preventable diseases, particularly those as serious and highly contagious as measles, making a comeback in Canada and around the globe.

March 12, 2019
·
2 min read
Business

Vapotherm Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Vapotherm, Inc., a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced today fourth quarter and fiscal year 2018 financial results.

March 12, 2019
·
21 min read
Policy

Janssen Submits Application to U.S. FDA Seeking Approval of DARZALEX® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible

Application supported by the Phase 3 MAIA study being reviewed under the FDA Real-Time Oncology Review pilot program

March 12, 2019
·
20 min read
Job Trends

Study Suggests Hip Replacement Patients Can Skip Hip Precautions

Low-risk patients undergoing a total hip replacement with a posterior approach can skip the standard hip precautions currently recommended for post-surgical recovery, according to a new study conducted at Hospital for Special Surgery, in New York City.

March 12, 2019
·
5 min read
Pharm Country

Oncoceutics Licenses Rights to ONC201 for Japan to Ohara Pharmaceutical Co., Ltd.

In addition, Ohara will receive a right of first refusal on the license of ONC201 for additional areas, including most of Asia and West Africa, and a right of first refusal for the company’s next generation compound, ONC206, in these territories.

March 12, 2019
·
3 min read
Business

UPDATE - Statement from the Chief Public Health Officer of Canada, Dr. Theresa Tam, on the current measles outbreak and vaccine hesitancy

In an era where, thanks to the success of vaccines, we are no longer familiar with these dangerous illnesses, some parents have come to fear the prevention more than the disease.

March 12, 2019
·
2 min read
BioCapital

Asthma and Allergy Foundation of America Announces 2019 Spring Allergy Capitals

McAllen, Texas, ranked most challenging city once again for spring allergies

March 12, 2019
·
2 min read
Business

Patrick Phillips to Keynote 2019 ARCS AMC Conference

Leading biologist will explore cutting-edge science in Frontiers of Aging address

March 12, 2019
·
3 min read